About NANO HOLDINGS
Nano Holdings is a Strategic Investment Holding Company
that combines equity and fund management
to create a unique business model.
NANO BOARD MEMBER
Atsushi Matsumura
Chairperson of the Board
Career Summary
| Apr. 1986 | Joined Nomura Securities, Co., Ltd |
|---|---|
| Jan. 2008 | Representative Director of Quiet Partners Inc. |
| Sep. 2010 | President of Whiz Partners Inc. |
| Mar. 2012 | Director of the Company |
| Mar. 2017 | Director of ALBERT Inc. |
| Dec. 2019 | Chairman of the board of AXEL MARK INC. |
| Apr. 2020 | Chairman of the board of Axcelead, Inc. |
| May 2020 | President and CEO of Whiz Partners Inc. |
| Mar. 2021 | Director of AXEL MARK INC. |
| Jun. 2021 | Director of the Company |
| Jan. 2023 | Chairman and Director of the Company |
| Jun. 2025 | Representative Director, Chairperson of the Board |
| Dec. 2025 | Representative Director, Chairman, President & CEO (Current) |
Shiro Akinaga
Representative Director, CTO
Career Summary
| Apr. 1981 | Joined Kyowa Hakko Kogyo Co., Ltd. (currently Kyowa Kirin Co., Ltd.) |
|---|---|
| Apr. 1994 | Senior Researcher at pharmaceutical research center of Kyowa Hakko |
| Apr. 2001 | Therapeutic Area Manager of oncology group at Drug Discovery Research Division of Kyowa Hakko |
| Apr. 2006 | Served as Director of International Development Department and Director of Clinical Development I Department, R&D Division of Kyowa Hakko |
| Oct. 2008 | Director, Clinical Development I Department, Development Division of Kyowa Hakko Kirin Co., Ltd. (currently Kyowa Kirin Co., Ltd.) |
| Mar. 2011 | Executive Officer (International Development) of Kyowa Hakko Kirin |
| Mar. 2013 | Fellow of Kyowa Hakko Kirin |
| Mar. 2017 | Director and CSO of AccuRna, Inc. |
| Nov. 2018 | Chairman of the board, CEO of AccuRna, Inc. |
| Jun. 2020 | Director of the Company |
| Sep. 2020 | Managing Director of R&D Division & CSO of the Company |
| Sep. 2022 | Representative Director and President of PrimRNA, Inc. |
| Dec. 2022 | President and CEO, Managing Director of R&D Division & CSO of the Company |
| Oct. 2023 | President and CEO |
| Dec. 2025 | Representative Director, CTO (Chief Technology Officer) (Current) |
Satoru Iino
Member of the Board, CIO
Career Summary
| Apr. 1989 | Joined Hitachi, Ltd. |
|---|---|
| Mar. 2000 | Joined CSK Venture Capital Co., Ltd. |
| Feb. 2004 | Director at the same company |
| Sep. 2010 | Executive Officer at With Partners Co., Ltd. |
| Mar. 2012 | Director at our company |
| Mar. 2015 | Managing Director and CIO of Fund Business at With Partners Co., Ltd. |
| Jun. 2021 | Director at our company; Director, COO and Co-CIO at With Partners Co., Ltd. |
| Apr. 2024 | President and Representative Director at With Partners Co., Ltd. |
| Jul. 2025 | Senior Advisor at our company |
| Dec. 2025 | Chief Investment Officer (CIO) of our company (Current) |
Nobuhiro Todokoro
Member of the Board, CGO
Career Summary
| Apr. 1989 | Joined Nitto Denko Corporation |
|---|---|
| Jun. 2015 | Executive Officer and General Manager of Information Functional Materials Division at the same company |
| Apr. 2017 | Executive Officer and Head of Information Functional Materials Division at the same company |
| Jun. 2017 | Director and Senior Executive Officer, Head of Information Functional Materials Division at the same company |
| Jun. 2019 | Director and Managing Executive Officer at the same company |
| Jun. 2021 | Director and Senior Managing Executive Officer at the same company |
| Jun. 2022 | Representative Director and Senior Managing Executive Officer at the same company |
| Jun. 2024 | President and CEO of Axcelead, Inc. |
| Jul. 2025 | Senior Advisor at our company |
| Dec. 2025 | Member of the Board, CGO (Chief Growth Officer) (Current) |
Takashi Matsuo
Member of the Board, CAO
Career Summary
| Apr. 1984 | Joined YAMAZEN CORPORATION |
|---|---|
| Apr. 1998 | General Manager of Corporate Planning Department of AUTOBACS SEVEN Co., Ltd. |
| Jun. 2002 | Director and Executive Officer in charge of Corporate Planning, Finance & Accounting, PR and IR and General Manager of Corporate Planning Management Office of AUTOBACS SEVEN Co., Ltd. |
| Jun. 2004 | Director and Officer in charge of Corporate Strategy Promotion and General Manager of Corporate Planning Management Office of AUTOBACS SEVEN Co., Ltd. |
| Apr. 2006 | Director and CSO and Head of Corporate Strategy Promotion of AUTOBACS SEVEN Co., Ltd. |
| May 2007 | Director and CSO, Head of Corporate Strategy Promotion and Co-COO and Head of Overseas Business Strategy Promotion of AUTOBACS SEVEN Co., Ltd. |
| Apr. 2010 | Representative Director and President of TAIYO Co., Ltd. |
| Apr. 2013 | Representative Director and President of AUTOBACS Nankai Ltd. |
| Apr. 2014 | Representative Director and President of AUTOBACS Fukuoka Ltd. |
| Apr. 2021 | Councilor of AUTOBACS Minami-Nihon Sales, Ltd. |
| Jun. 2023 | Audit & Supervisory Board Member of the Company |
| Aug. 2023 | Representative Director of Value Create Inc. (Current) |
| Jun. 2025 | Director of the Company |
| Dec. 2025 | Member of the Board, CAO (Chief Administrative Officer) (Current) |
Ichiro Nakatomi
Member of the Board, CNO
Career Summary
| Apr. 1978 | Joined Hisamitsu Pharmaceutical Co., Inc. |
|---|---|
| Jan. 1991 | Vice President of Business Development at TheraTech Inc. (USA) |
| Oct. 1993 | Concurrent position: President and Representative Director of Japan Ceratec Co., Ltd. |
| Jun. 1996 | President and CEO of our company |
| Aug. 2008 | Outside Director at iPS Academia Japan, Inc. |
| Oct. 2013 | Outside Director at OP NanoPharma Co., Ltd. (Taiwan) (Current) |
| Jul. 2014 | Outside Director at iPS Portal Co., Ltd. |
| May 2020 | Representative Director at Avida Science Co., Ltd.; Advisor at Oji Pharma Co., Ltd. (Current) |
| Apr. 2021 | Advisor at Tokyo University of Science Educational Corporation (Current) |
| May 2025 | Special Advisor at our company |
| Dec. 2025 | Member of the Board, CNO (Chief Network Officer) (Current) |
Hajime Kurozu
Member of the Board
Career Summary
| Apr. 1982 | Joined Nomura Securities, Co., Ltd. |
|---|---|
| Apr. 2003 | Various senior positions at Nomura Securities, Co., Ltd., including General Manager of Corporate Finance Department I and General Manager of Osaka Finance Department I |
| Oct. 2007 | Seconded to Nomura Asset Management Co., Ltd. |
| Dec. 2010 | Seconded to LIC Nomura Mutual Fund Asset Management Pvt. Ltd. (India) |
| Mar. 2016 | Various senior positions at Rating and Investment Information, Inc., including Managing Executive Officer and General Manager of RM Division in charge of RM Division, Market Sales Department, and Hong Kong Office; Head of Hong Kong Office; Manager in charge of Marketing Division |
| Apr. 2017 | Managing Executive Officer in charge of RM Division, Market Sales Department, and Hong Kong Office at Rating and Investment Information, Inc. |
| Mar. 2019 | Senior Managing Executive Officer responsible for Sales, and in charge of Marketing Division, and Head of Hong Kong Office at Rating and Investment Information, Inc. |
| Mar. 2021 | Director and Senior Managing Executive Officer responsible for Sales, and in charge of Marketing Division, and Head of Hong Kong Office at Rating and Investment Information, Inc. |
| Mar. 2024 | President and CEO of P-ALM Capital Co., Ltd. (Current) |
| Jun. 2024 | Audit & Supervisory Board Member of the Company |
| Dec. 2025 | Director at our company (Current) |
Takashi Ejiri
Member of the Board
Career Summary
| Apr. 1969 | Registered as Attorney |
|---|---|
| Nov. 1977 | Partner at Masuda Ejiri Law Office (now Nishimura & Asahi Law Firm) |
| Sep. 1986 | Vice Chairman of International Exchange Committee, Japan Federation of Bar Associations |
| Nov. 1998 | Auditor at USEN Corporation (formerly Yusen Broadband Networks Co., Ltd.) |
| Jun. 2003 | Auditor at Aozora Bank, Ltd. |
| Jun. 2004 | Auditor at Ando Construction Co., Ltd. (now Ando Hazama Corporation) |
| Jun. 2006 | Auditor at Kagome Co., Ltd. |
| May 2010 | Auditor at Mitsubishi UFJ Securities Holdings Co., Ltd.; Auditor at Mitsubishi UFJ Morgan Stanley Securities Co., Ltd.; Outside Auditor at DIP Corporation |
| Aug. 2010 | Member of Nishimura & Asahi Law Firm |
| Mar. 2017 | Outside Director at ALBERT Inc. |
| Jun. 2017 | Outside Director at OBIC Co., Ltd. (Current) |
| Aug. 2017 | Senior Partner at ITN Law Firm (formerly Natori Law Office) (Current) |
| Dec. 2019 | Outside Director (Audit Committee Member) at Axel Mark Inc. |
| Dec. 2025 | Director at our company (Current) |
Seiichiro Wada
Audit & Supervisory Board Member
Career Summary
| Apr. 1986 | Joined Nomura Securities Co., Ltd. |
|---|---|
| Jul. 2008 | Head of Real Estates Investment Business Department of Nomura Securities Co., Ltd. |
| Apr. 2013 | Head of Overseas Sales Department of Nomura Real Estate Asset Management Co., Ltd. |
| Oct. 2014 | Managing Director of Nomura Real Estate Asset Management Co., Ltd. |
| Apr. 2015 | Executive Managing Director of Nomura Real Estate Asset Management Co., Ltd. |
| Apr. 2017 | Audit and supervisory board member of Nomura Real Estate Asset Management Co., Ltd. |
| Jun. 2023 | Auditors to the Company |
| Jul. 2023 | Managing Director, Whiz Partners Inc. |
| Dec. 2025 | Full-time Auditor at our company (Current) |
Niro Sakamoto
Audit & Supervisory Board Member
Career Summary
| Apr. 1983 | Joined Kyowa Hakko Kogyo Co., Ltd. (currently Kyowa Kirin Co., Ltd.) |
|---|---|
| Apr. 2006 | Director of Biochemical Planning and Management Department of Kyowa Hakko |
| Jul. 2007 | Executive Officer and General Manager of Corporate Planning Department of Daiichi Fine Chemical Co., Ltd |
| Apr. 2010 | Director of Accounting Department of Kyowa Hakko Kirin Co., Ltd. (currently Kyowa Kirin Co., Ltd.) |
| Apr. 2012 | Executive Officer and Director of Corporate Planning Department of Kyowa Hakko Kirin |
| Apr. 2015 | Executive Officer and Director of General Affairs Department of Kyowa Hakko Kirin |
| Mar. 2021 | Outside Company Auditor of Chiome Bioscience Inc. |
| Nov. 2021 | Director of Administration Department of Kyulux, Inc. (Current) |
| Mar. 2025 | Outside Director (Audit and Supervisory Committee Member) of Chiome Bioscience Inc. (Current) |
| Jun. 2025 | Auditors to the Company |
| Dec. 2025 | Outside Director at our company (Current) |
Takuma Shimizu
Audit & Supervisory Board Member
Career Summary
| Oct. 2002 | Registration as an Attorney at law Joined Asahi and Koma Law Office (currently Nshimura & Asahi) |
|---|---|
| Apr. 2007 | Partner of Iota law and patent offices |
| Apr. 2012 | Part-time Professor of Faculty of Law of Department of Law of Keio University (Current) |
| Sep. 2012 | Audit and supervisory board member of ABEJA, Inc. (Current) |
| Oct. 2014 | Outside Company Auditor of CRE, Inc. |
| Oct. 2015 | Outside Director, Audit and Supervisory Committee Member of CRE, Inc. (Current) |
| Mar. 2017 | Representative Partner of Iota law and patent offices (Current) |
| Mar. 2018 | Supervisory Officers of KAJIMA Private REIT, Inc. (Current) |
| Mar. 2019 | Outside Company Auditor of CBcloud Co., Ltd. (Current) |
| Apr. 2022 | Outside Company Auditor of DUAL Holdings Corp. |
| Mar. 2024 | Outside Director of DUAL Holdings Corp. |
| Jun. 2025 | Auditors to the Company |
| Dec. 2025 | Auditors to the Company (Current) |
Corporate Profile
| Corporate Name | Nano Holdings, Inc. |
|---|---|
| Location |
Tokyo Office (Head office)Atago Green Hills MORI Tower 26F LabShonan Health Innovation Park (ADDP) |
| Group Company | Nano Bridge Investment Co., Ltd. |
| Establishment | June 14, 1996 |
| Representative Director |
Representative Director, Chairman, President & CEOAtsushi Matsumura Representative Director, CTOShiro Akinaga |
| Scopes of Business | Investment business and research, development, and manufacturing of pharmaceuticals. |
| Subsidiary Company | PrimRNA Co., Ltd. |
| NanoCarrier US. Inc. | |
| Nano Bridge Investment Co., Ltd. | |
| History | Page More |
| Access | Page More |